Form D · Pharmaceuticals
Lantern Pharma Inc.
Dallas, TX · CIK 0001763950
Offering snapshot reported May 21, 2026 · SEC filing
- Reported sold
- $0 Offering amount: $0
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2026 | Initial | $0 | No comparison | 6 | SEC filing |
| Mar 18, 2019 | Initial | $2,385,005 | No comparison | 5 | SEC filing |
| Jan 14, 2019 | Initial | $535,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584796
The investors paid nothing for the warrants. The warrants were issued as additional consideration for shares of common stock purchased in a concurrent registered offering.
private placement of common stock purchase warrants;claiming additional Section 4(a)(2) exemption
Source: Form D, filed May 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arunkumar Asaithambi | Director |
| Kishor G. Bhatia | Executive |
| Vijay Chandru | Director |
| John Fucci | Director |
| Donald Jeffrey Keyser | Director |
| David Keyser | Director |
| Maria Maccecchini | Director |
| David R. Margrave | Executive |
| Lee T. Schalop | Director |
| Panna Sharma | Director, Executive |
| David S. Silberstein | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1920 Mckinney Avenue, 7 Th Floor
Dallas, TX, 75201
Phone: (972) 277-1136
Dallas, TX, 75201
Phone: (972) 277-1136